University of Liverpool scientists have discovered how a protein linked to a severe form of childhood epilepsy is positioned within nerve cells, providing new insights into a rare genetic neurological disorder.
CDKL5 deficiency disorder (CDD) is a rare neurological condition that causes severe epilepsy beginning in early infancy, alongside significant developmental difficulties. It is caused by mutations in a gene called CDKL5, which produces a protein essential for normal brain development and function.
CDD is estimated to occur in approximately 1 in 40,000 to 60,000 live births worldwide. Although scientists have known about CDKL5 for a number of years, little is known about how this protein works inside nerve cells and why mutations cause such profound neurological problems. New research led by Professor of Mechanistic Cell Biology, Ben Goult now provides a framework for understanding how CDKL5 works and how mutations might disrupt brain development.
A crucial new finding is the identification of a previously unrecognised molecular docking mechanism that attaches CDKL5 to the structural framework of synapses. This discovery reveals how CDKL5 is positioned at synapses, something that has, until now, remained unclear despite years of research into this protein.
Importantly, the study shows that where CDKL5 is located within nerve cells is just as important as what it does. Disrupting the newly discovered anchoring mechanism changed the organisation of nerve cells, highlighting the vital role this positioning plays in normal brain function.
Dr Yasumi Otani, first author of the study and former PhD student in the Institute of Systems, Molecular and Integrative Biology said: “What was particularly striking was that changing just a single amino acid at the very end of CDKL5 was enough to dramatically alter its localisation in nerve cells. This shows just how critical the final residues of the protein are for keeping CDKL5 in the right place at synapses.”
Researchers also identified a direct connection between CDKL5 and the cell's mechanical machinery. The team found that CDKL5 binds directly to talin, a protein that changes shape in response to physical forces. Experiments in cultured cells showed that disrupting this interaction, or reducing the forces generated by the cell, altered where CDKL5 was positioned. This suggests a previously unrecognised way in which mechanical forces could influence the location of CDKL5 activity.
Overall, the findings could reshape scientists' understanding of how disease-causing CDKL5 mutations lead to neurological problems. Many mutations associated with CDKL5 deficiency disorder shorten the protein, removing the docking sequence identified. However, these results suggest that some of these mutations may cause problems not only by affecting the protein itself, but also by preventing it from reaching the correct location within nerve cells.
Professor Ben Goult said: “Much of the research into CDKL5 deficiency disorder has focused on the activity of the enzyme itself. Our work highlights another potentially crucial factor: where that activity takes place. By identifying the molecular interactions that position CDKL5, we can begin to understand how the protein is organised within synapses and why disrupting this organisation might interfere with communication between nerve cells.”
Andreas Borg, Founder of CURE5, a parent-led foundation dedicated to finding a cure for CDKL5 Deficiency Disorder said: “Seeing how profoundly CDKL5 loss affects so many systems in the body also gives us hope that new opportunities for therapeutic intervention remain to be discovered. The new understanding of the protein's location and function identified in this work opens up one such possibility. As parents, even the smallest improvements in our children's lives mean the world.”
The research was carried out in collaboration with researchers at the University of Helsinki, Finland.
The paper, ‘Cyclin-dependent kinase-like 5 (CDKL5) binds talin and is anchored at the postsynaptic density by direct PDZ interactions’, was published in Science Advances (DOI:10.1126/sciadv.aed3338).
Journal
Science Advances
Article Title
Cyclin-dependent kinase-like 5 (CDKL5) binds talin and is anchored at the postsynaptic density by direct PDZ interactions
Article Publication Date
20-Nov-2026